Asano R, Nagase S, Aoki T, Ueda J, Tsuji A, Asakura K
Circ Rep. 2025; 7(3):212-215.
PMID: 40066214
PMC: 11890299.
DOI: 10.1253/circrep.CR-24-0179.
Luijten D, Rodenburg T, Bogaard H, Kianzad A, Ruigrok D, Croon P
PLoS One. 2025; 20(2):e0317826.
PMID: 40009598
PMC: 11864536.
DOI: 10.1371/journal.pone.0317826.
Yogeswaran A, Funderich M, Olschewski H, Kovacs G, Kiely D, Lawrie A
ERJ Open Res. 2025; 11(1).
PMID: 40008170
PMC: 11849103.
DOI: 10.1183/23120541.00466-2024.
Park J, Choi Y, Min J, Lee J, Shim G
Pharmaceutics. 2025; 17(2).
PMID: 40006591
PMC: 11859843.
DOI: 10.3390/pharmaceutics17020224.
Kazimierczyk R, Szumowski P, Nekolla S, Malek L, Blaszczak P, Sobkowicz B
J Clin Med. 2025; 14(4).
PMID: 40004594
PMC: 11856495.
DOI: 10.3390/jcm14041062.
Arduous management in treatment of elderly patient with pulmonary arterial hypertension and cardiopulmonary comorbidities.
Enomoto Y, Kusaka K, Sato K, Takeda K, Kawashima M, Morio Y
Respir Med Case Rep. 2025; 53:102174.
PMID: 39980612
PMC: 11840548.
DOI: 10.1016/j.rmcr.2025.102174.
Expert consensus on liver transplantation perioperative evaluation and rehabilitation for acute-on-chronic liver failure.
Lv H, Zheng H, Liu J, Cai Q, Ren Y, Yi H
Liver Res. 2025; 6(3):121-129.
PMID: 39958201
PMC: 11791836.
DOI: 10.1016/j.livres.2022.08.002.
Four-Dimensional Magnetic Resonance Pulmonary Flow Imaging for Assessing Pulmonary Vasculopathy in Patients with Postcapillary Pulmonary Hypertension.
Nuche J, Ponz I, Sanchez Sanchez V, Bobeda J, Gaitan A, Lopez-Linares K
J Clin Med. 2025; 14(3).
PMID: 39941600
PMC: 11818231.
DOI: 10.3390/jcm14030929.
Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing.
Tarras E, Singh I, Kreiger J, Joseph P
J Clin Med. 2025; 14(3).
PMID: 39941482
PMC: 11818252.
DOI: 10.3390/jcm14030804.
Methods for establishing animal models of persistent pulmonary hypertension of the newborn: A systematic literature analysis.
Cai M, Zhou S, Luo P, Hu C, Sun L
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2025; 49(9):1477-1494.
PMID: 39931778
PMC: 11814388.
DOI: 10.11817/j.issn.1672-7347.2024.230539.
Vasoreactive testing prevalence and characteristics in patients with idiopathic pulmonary arterial hypertension.
Natalia G, Lapshin K, Berezina A, Zlobina I, Ryzhkov A, Matakaeva Z
Ann Thorac Med. 2025; 20(1):62-70.
PMID: 39926400
PMC: 11804955.
DOI: 10.4103/atm.atm_189_24.
Development of the pulmonary fibrosis, pulmonary vascular resistance, six minute walk distance, B-type natriuretic peptide, age (PVD-B65) risk score for patients with chronic lung disease and pulmonary hypertension.
Gayen S, Pescatore J, Bittner M, Naranjo M, Criner G, Weaver S
BMC Pulm Med. 2025; 25(1):69.
PMID: 39923026
PMC: 11807298.
DOI: 10.1186/s12890-025-03538-8.
Impact of diabetes mellitus on long-term survival after transcatheter mitral valve edge-to-edge repair.
Schmitt V, Geyer M, Born S, Bachmann K, Schnitzler K, Hell M
Int J Cardiol Heart Vasc. 2025; 56:101601.
PMID: 39917728
PMC: 11800078.
DOI: 10.1016/j.ijcha.2025.101601.
Prognosis of pulmonary hypertension in patients with hypertrophic cardiomyopathy: A multicenter propensity score matching study.
Ma H, Xu F, Liu L, Kong H, Luo R, Liu M
Int J Cardiol Heart Vasc. 2025; 56:101605.
PMID: 39897413
PMC: 11783049.
DOI: 10.1016/j.ijcha.2025.101605.
Elevated Lp(a) and its association with cardiac fibrosis in group II pulmonary hypertension patients.
Albulushi A, Al-Asmi S, Al-Abri M, Al-Farhan H
Future Cardiol. 2025; 21(2):95-102.
PMID: 39895237
PMC: 11812331.
DOI: 10.1080/14796678.2025.2460909.
Deep Learning-Based Identification of Echocardiographic Abnormalities From Electrocardiograms.
Fujiki G, Kodera S, Setoguchi N, Tanabe K, Miyaji K, Kushida S
JACC Asia. 2025; 5(1):88-98.
PMID: 39886205
PMC: 11775793.
DOI: 10.1016/j.jacasi.2024.10.012.
The tricuspid annular plane systolic excursion/PASP ratio's accuracy and validity in assessing the right ventricular function: A narrative review.
Sercelik A, Askin L
J Res Med Sci. 2025; 29:75.
PMID: 39871874
PMC: 11771819.
DOI: 10.4103/jrms.jrms_350_24.
Predictive Value of the DETECT Algorithm for Pulmonary Arterial Hypertension in Systemic Sclerosis: Findings from an Italian Observational Study.
Stano S, Iannone C, DAgostino C, Pellico M, Urso L, Papa N
J Clin Med. 2025; 14(2.
PMID: 39860644
PMC: 11765971.
DOI: 10.3390/jcm14020638.
Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions.
Dragoi I, Rezus C, Burlui A, Bratoiu I, Rezus E
Medicina (Kaunas). 2025; 61(1).
PMID: 39859001
PMC: 11766816.
DOI: 10.3390/medicina61010019.
The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil.
Kedzierski P, Banaszkiewicz M, Florczyk M, Pilka M, Manczak R, Wieteska-Milek M
Biomedicines. 2025; 13(1.
PMID: 39857754
PMC: 11760442.
DOI: 10.3390/biomedicines13010172.
